Evidence map›Paper›PMID 31015737›Full record

ArticleActa pharmacologica Sinica2019

Publisher Correction: Inflammation-activated CXCL16 pathway contributes to tubulointerstitial injury in mouse diabetic nephropathy.

Ze-Bo Hu, Kun-Ling Ma, Yang Zhang, Gui-Hua Wang, Liang Liu, Jian Lu, Pei-Pei Chen, Chen-Chen Lu, Bi-Cheng Liu

Open access · bronzeAbstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Acta pharmacologica Sinica, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 96% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Ze-Bo HuInstitute of Nephrology, Zhongda Hospital, School of Medicine, Southeast University, Nanjing 210009, China.
Kun-Ling MaInstitute of Nephrology, Zhongda Hospital, School of Medicine, Southeast University, Nanjing 210009, China. klma05@163.com.
Yang ZhangInstitute of Nephrology, Zhongda Hospital, School of Medicine, Southeast University, Nanjing 210009, China.
Gui-Hua WangInstitute of Nephrology, Zhongda Hospital, School of Medicine, Southeast University, Nanjing 210009, China.
Liang LiuInstitute of Nephrology, Zhongda Hospital, School of Medicine, Southeast University, Nanjing 210009, China.
Jian LuInstitute of Nephrology, Zhongda Hospital, School of Medicine, Southeast University, Nanjing 210009, China.
Pei-Pei ChenInstitute of Nephrology, Zhongda Hospital, School of Medicine, Southeast University, Nanjing 210009, China.
Chen-Chen LuInstitute of Nephrology, Zhongda Hospital, School of Medicine, Southeast University, Nanjing 210009, China.
Bi-Cheng LiuInstitute of Nephrology, Zhongda Hospital, School of Medicine, Southeast University, Nanjing 210009, China.
Zhongda Hospital Southeast University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The REFERENCES 1-35 are wrong because of the error in the process of typesetting.

Identifiers

PMID31015737
PMCPMC6786295
OpenAlexW2942051152

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.